Ding Yufeng

Ding Yufeng


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
ZDZhi-Jie Deng
Zhi-Jie Deng
LGLin Gui
Lin Gui
JCJing Chen
Jing Chen
SPShun-Shun Peng
Shun-Shun Peng
DYDing Yufeng
Ding Yufeng
WAWei Anhua
Wei Anhua
Background:Medication therapy management (MTM) services is a method that can effectively improve patients’ conditions, but the efficacy of economic and humanistic outcomes remain unclear. This systematic review and meta-analysis aim to use economic, clinical and humanistic outcomes to evaluate the multi-benefits of MTM services.Method:A systematic review and meta-analysis was conducted by retrieving PubMed, EMBASE, the Cochrane Library andClinicalTrial.govfrom the inception to April 2022. There were two reviewers screening the records, extracting the data, and assessing the quality of studies independently.Results:A total of 81 studies with 60,753 participants were included. MTM services were more effective in clinical outcomes with decreasing the rate of readmission (OR: 0.78; 95% CI: 0.73 to 0.83; I2= 56%), emergency department visit (OR: 0.88; 95% CI: 0.81 to 0.96; I2= 32%), adverse drug events (All-cause: OR: 0.68; 95% CI: 0.56 to 0.84; I2= 61%; SAE: OR: 0.51; 95% CI: 0.33 to 0.79; I2= 35%) and drug-related problems (MD: −1.37; 95% CI: −2.24 to −0.5; I2= 95%), reducing the length of stay in hospital (MD: −0.74; 95% CI: −1.37 to −0.13; I2= 70%), while the economic and humanistic outcomes were less effective.Conclusion:Our systematic review and meta-analysis demonstrated that MTM services had great ability to improve patients’ clinical conditions while the efficacy of economic and humanistic outcomes, with some of the outcomes showing high degree of heterogeneity and possible publication bias, required more future studies to provide stronger evidence.Systematic Review Registration: [https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=349050], identifier [CRD42022349050].

1 December 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
XYXiaofan Yang
Xiaofan Yang
DYDing Yufeng
Ding Yufeng
MXMiao Xiao
Miao Xiao
XLXin Liu
Xin Liu
JRJinlan Ruan
Jinlan Ruan
PXPingping Xue
Pingping Xue

29 December 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
GWGuangjie Wu
Guangjie Wu
SGShiwei Gong
Shiwei Gong
HCHongbing Cai
Hongbing Cai
DYDing Yufeng
Ding Yufeng
China ranks first amongst the countries for the abuse of antibacterials. Essential antibacterials could help solve the problem. The aim of the work is to evaluate the availability, price and affordability of essential antibacterials in Hubei province, China. The standardized methodology developed by the World Health Organization and Health Action International was used to collect data on the availability and prices of 16 antibacterials in 5 cities of Hubei province, China. First, in total, the median availability of originator brands and lowest-priced generics for the essential antibacterials was low, 3.0% (0.0, 18.2%) and 33.3% (0.0, 87.9%) for each, respectively. Second, the median price ratio of originator brands for the antibacterials was 20.30 (4.71, 35.80), while for generics, it was 0.49 (0.07, 1.18). Third, the affordability of originator brands for the antibacterials was 28.14 (21.70, 41.90) times the daily wages of an unskilled government worker, while for generics, the affordability was 0.35 (0.04, 6.11). Finally, we found that in Hubei province, lowest-priced generics for essential antibacterials with (fairly) high availability and relatively low price included Amoxicillin/Clavulanic Acid, Ceftazidime, Metronidazole, Gentamicin Sulfate and Ceftriaxone. The prices of lowest-priced generics for essential antibacterials in Hubei province were reasonable, and in tertiary hospitals the availability was the highest, while in secondary and primary hospitals, it was relatively lower. Originator brands were not only extremely expensive but also difficult to obtain. Measures should be taken to improve the availability of essential antibacterials and the affordability of originator brands.

9 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XFXiangling Feng
Xiangling Feng
YSYouquan Shi
Youquan Shi
DYDing Yufeng
Ding Yufeng
HZHeng Zheng
Heng Zheng

2 September 2021 in Current Medical Science
Verified
Journal Article
Closed access
PDF file
WLWeijie Li
Weijie Li
MXMei-Jun Xia
Mei-Jun Xia
SGShiwei Gong
Shiwei Gong
DYDing Yufeng
Ding Yufeng

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
TWTao Wang
Tao Wang
YCYang Cai
Yang Cai
WSWen Song
Wen Song
RCRuibao Chen
Ruibao Chen
DHDunmei Hu
Dunmei Hu
DYDing Yufeng
Ding Yufeng
Objective. To investigate the inhibitory effect of ethyl acetate extracts of Impatiens balsamina L. on prostate cancer cells. Methods. Impatiens balsamina L. was extracted to get water, ethanol, oil ether, ethyl acetate, and butanol extracts. CCK-8 assay was used to detect the inhibitory effect. Apoptosis rates and cell cycle distribution were detected by flow cytometry. Transwell assay was performed to test the ability of migration. The expressions of Bcl-2, Bax, cleaved-caspase-3, p-ERK, ERK, p-AKT, AKT, cyclin D1, cyclin E, and MMP2 were detected by Western blot. Results. Ethyl acetate extracts had the strongest inhibitory effect. After being treated with different concentrations of ethyl acetate extracts, the percentage of G0/G1 phase increased significantly, cyclin D1 and cyclin E expression decreased, apoptosis rate was significantly higher, and the ability of migration of PC-3 and RV1 was inhibited significantly. Western blot showed that the expressions of Bcl-2, p-ERK, and p-AKT were significantly decreased, but the expressions of Bax and caspase-3 cleavage were increased. Conclusions. Impatiens balsamina L. inhibited the proliferation of human prostate cancer cells; ethyl acetate extracts have the strongest effect. It could inhibit cell proliferation and migration, cause G1 phase arrest, and induce apoptosis probably through inhibition of the AKT and ERK pathways.